What is the equity of Bergenbio A this year?
Bergenbio A has equity of 127.48 M NOK this year.
Bergenbio A Equity 2024
Bergenbio A Equity
127.48 M NOK
Ticker
BGBIO.OL
ISIN
NO0010650013
WKN
A2DPC0
In 2024, Bergenbio A's equity was 127.48 M NOK, a 44.04% increase from the 88.5 M NOK equity in the previous year.
Bergenbio A Aktienanalyse
What does Bergenbio A do?
Bergenbio ASA is a Norwegian company that focuses on the development of drugs that specifically target cancer-causing pathways in the body. The company was founded in 2007 and is based in Bergen, Norway. Bergenbio A ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Bergenbio A's Equity
Bergenbio A's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bergenbio A's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Bergenbio A's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Bergenbio A's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Bergenbio A’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Bergenbio A stock
What was the equity of Bergenbio A compared to the previous year?
The equity of Bergenbio A has increased/decreased by 44.04% increased compared to the previous year.
What impact does a high equity have on investors of Bergenbio A?
A high equity is advantageous for investors of Bergenbio A as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Bergenbio A?
A low equity can be a risk for investors of Bergenbio A, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Bergenbio A affect the company?
An increase in equity of Bergenbio A can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Bergenbio A affect the company?
A reduction in equity of Bergenbio A can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Bergenbio A?
Some factors that can affect the equity of Bergenbio A include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Bergenbio A so important for investors?
The equity of Bergenbio A is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Bergenbio A take to change the equity?
To change equity, Bergenbio A can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Bergenbio A pay?
Over the past 12 months, Bergenbio A paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bergenbio A is expected to pay a dividend of 0 NOK.
What is the dividend yield of Bergenbio A?
The current dividend yield of Bergenbio A is .
When does Bergenbio A pay dividends?
Bergenbio A pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bergenbio A?
Bergenbio A paid dividends every year for the past 0 years.
What is the dividend of Bergenbio A?
For the upcoming 12 months, dividends amounting to 0 NOK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bergenbio A located?
Bergenbio A is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bergenbio A kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bergenbio A from 10/29/2024 amounting to 0 NOK, you needed to have the stock in your portfolio before the ex-date on 10/29/2024.
When did Bergenbio A pay the last dividend?
The last dividend was paid out on 10/29/2024.
What was the dividend of Bergenbio A in the year 2023?
In the year 2023, Bergenbio A distributed 0 NOK as dividends.
In which currency does Bergenbio A pay out the dividend?
The dividends of Bergenbio A are distributed in NOK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bergenbio A
Our stock analysis for Bergenbio A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bergenbio A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
